CNTX — Context Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareMicro Cap
- $21.08m
- $6.63m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -6.38 | 6.64 | -10.5 | -14.8 | -24 |
Depreciation | |||||
Non-Cash Items | 2.99 | -9 | 3.88 | 1.55 | 1.13 |
Unusual Items | |||||
Purchased R&D | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.562 | 1.32 | -2.22 | -0.278 | 1.78 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | -2.84 | -1.03 | -8.8 | -13.5 | -21 |
Capital Expenditures | — | — | — | -0.037 | 0 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | -0.25 | -0.5 | 0 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | — | — | -0.25 | -0.537 | 0 |
Financing Cash Flow Items | — | — | — | -0.102 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.96 | 1.15 | 58.4 | -0.102 | 0 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.879 | 0.114 | 49.3 | -14.2 | -21 |